What’s the full story? SMCI’s stock, up 38% year-to-date, trades at 16x F2025E P/E, with the Goldman analysts viewing risk-reward as unfavorable amid valuation, competition, and margin concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback